Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;174 Suppl 1(Suppl Suppl 1):S130-S159.
doi: 10.1111/bph.13879.

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels

Affiliations

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Ligand-gated ion channels

Stephen Ph Alexander et al. Br J Pharmacol. 2017 Dec.

Abstract

The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13879/full. Ligand-gated ion channels are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

PubMed Disclaimer

Conflict of interest statement

The authors state that there are no conflicts of interest to declare.

References

    1. Abi‐Dargham A et al. (1993) [8419547]
    1. Acker BA et al. (2008) [18490160]
    1. Ahrens J et al. (2009) [19204413]
    1. 4. Akopian AN et al. (2000) [10923674]
    1. Albaugh PA et al. (2002) [12408715]